[ Price : $8.95]
GSK decides not to seek FDA approval for otilimab, an investigational monoclonal antibody targeting granulocyte-macrophage colony-...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection extension entitled 510(k) Third-Party Review Program.[ Price : $8.95]
FDA posts eight generic drug research priority initiatives for FY 2023.[ Price : $8.95]
FDA says Baxter International has issued an urgent medical device correction for its WatchCare incontinence system that may cause ...[ Price : $8.95]
FDA publishes a guidance to help agency staff request additional information needed to make decisions on medical device marketing ...[ Price : $8.95]
The Medical Device Innovation Consortium releases its first medical device manufacturer benchmark report on cybersecurity maturity...[ Price : $8.95]
FDA commissioner Robert Califf says he hopes Congress will include regulation of laboratory-developed tests and several other issu...[ Price : $8.95]
FDA postpones an 11/18 joint advisory committee that was going to vote on a Laboratoire HRA Pharma supplemental NDA for Opill (nor...